European Monitoring Centre for Drugs and Drug Addiction. (2013). Synthetic cannabinoids in Europe. Lisbon: Author.
Abstract: Synthetic cannabinoids, or more correctly, synthetic cannabinoid receptor agonists, mimic the effect of cannabis and are the largest group of compounds monitored at European level by the EU Early warning system on new psychoactive substances (EWS). ’Legal high’ products containing synthetic cannabinoids have probably been sold as herbal smoking mixtures since at least 2006. These products do not necessarily contain tobacco or cannabis but when smoked, produce effects similar to those of cannabis. They have been subject to innovative marketing approaches and are widely available on the Internet and in some shops in urban areas (often called ’head’ or ’smart’ shops).
Keywords: psychoactive substances; cannabis product; cannabinoids; smoking; tobacco in any form; AOD effects and AODR problems; adverse drug effect; AOD product advertising; AOD sales outlet; international area; Europe; European Union
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). Synthetic drug production in Europe. Lisbon: Author.
Abstract: Europe has a long history of producing and consuming synthetic drugs. The region remains important today for the production of these substances, with manufacture taking place for both domestic consumption and export to other parts of the world. In terms of both production and use, three substances dominate the European market for synthetic drugs: amphetamine (usually the sulphate salt), ecstasy-type drugs, especially methylenedioxymethamphetamine (MDMA), and methamphetamine (usually the hydrochloride salt).
Keywords: psychoactive substances; illegal production of drugs; AOD consumption; drug trafficking; amphetamines; MDMA; ecstasy; international area; Europe; European Union
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). Trends in heroin use in Europe : what do treatment demand data tell us? Lisbon: Author.
Abstract: The current number of problem opioid users in Europe can be estimated atabout 1.4 million, or 0.41 % of the adult population, with heroin being by far the most widely used opioid. Heroin use has developed along different timelines; several western European countries faced increases from the 1970s onward, whereas countries in Central and Eastern Europe saw a development in heroin use in the 1990s and later. Recent analyses of multiple indicators suggest that Europe may be witnessing a longer-term decline in heroin use, although countries show varying patterns and trends.
Keywords: AOD user; AOD consumption; opioids in any form; heroin; treatment and maintenance; epidemiology; survey; statistical data; international area; Europe; European Union
|
Groupement romand d'études des addictions. (2013). 3c LStup – restriction du champ d'application. Yverdon-les-Bains: Groupement romand d'études des addictions (GREA).
Abstract: L’OFSP a tranché dans le débat sur la portée du nouvel article 3c LStup. Celui-ci ne concernera finalement que les drogues illégales, excluant de son champ d’application l’alcool, le tabac et les comportements problématiques.
Keywords: government and politics; laws and regulations; public policy on AOD; amendment; drug laws; illicit drug; chemical addiction; psychoactive substances; licit drug; alcohol; tobacco in any form; nonchemical addiction; addictive behavior; commentary; Switzerland
|
Hartig, K. (2013). 10 gute Gründe für den Besuch einer Selbsthilfegruppe (Deutsche Hauptstelle für Suchtfragen, Ed.). Hamm: Deutsche Hauptstelle für Suchtfragen (DHS).
Abstract: Selbsthilfe ist für Sie da. Diese Information richtet sich an alle Menschen mit Suchtproblemen, von A wie Alkohol bis Z wie Zocken. Und an deren Angehörige.
Keywords: self-help group; AOD dependent; family; relative (related person); chemical addiction; alcohol; nonchemical addiction; pathological gambling; Germany
|
JES Bundesverband Leben mit Drogen. (2012). Empfehlungen zum Umgang mit Substitutionsmitteln in Haushalten mit Kindern und Jugendlichen. Berlin: Author.
Abstract: Die Versorgung von Müttern und Vätern mit Substituten die mit ihrem Kind in einem Haushalt leben hat in der Vergangenheit aufgrund von Unfällen und Fahrlässigkeiten für viele Diskussionen gesorgt. JES gibt in seiner Broschüre wichtige Hinweise zur Lagerung von Substituten im Haushalt mit Kindern und gibt Ärzten wichtige Infos zum Umgang mit substituierten Müttern und Vätern.
Keywords: family; child; parent; AOD dependence; chemical addiction; treatment and maintenance; drug substitution therapy; methadone; codeine; buprenorphine; recommendations or guidelines; risk; Germany
|
National Treatment Agency for Substance Misuse. (2003). Evidence update January 2013 : alcohol use disorders : harmful drinking and alcohol dependence. London: National Treatment Agency for Substance Misuse (NHS).
Abstract: A summary of selected new evidence relevant to NICE clinical guideline 115 ’alcohol use disorders : diagnosis, assessment and management of harmful drinking and alcohol dependence’ (2011)
Keywords: AOD use, abuse, and dependence; licit drug; chemical addiction; alcohol abuse; diagnosis; identification and screening; intervention (persuasion to treatment); treatment and maintenance; United Kingdom
|
Bundesamt für Gesundheit. (2013). Faktenblatt : Entwicklung des Alkoholkonsum der Schweiz seit den 1880er Jahren basierend auf den Daten der Eidgenössischen Alkoholverwaltung EAV. Bern: Bundesamt für Gesundheit (BAG), Direktionsbereich Öffentliche Gesundheit, Sektion Alkohol.
Keywords: AOD consumption; licit drug; alcohol abuse; alcoholic beverage; history; statistical data; Switzerland
|
Sucht Schweiz. (2009). Factsheet Schnupftabak. Lausanne: Author.
Keywords: licit drug; tobacco in any form; tobacco product; health; risk assessment; chemical addiction; AOD use, abuse, and dependence; AOD effects and AODR problems; AODR disorder; cancer; fact sheet; Switzerland
|
Addiction Suisse. (2009). Factsheet tabac à priser. Lausanne: Author.
Keywords: licit drug; tobacco in any form; tobacco product; health; risk assessment; chemical addiction; AOD use, abuse, and dependence; AOD effects and AODR problems; AODR disorder; cancer; fact sheet; Switzerland
|